My Quote Request
No products added yet
6505-01-051-9279
20 Products
ORASONE
PREDNISONE TABLETS,USP
NSN, MFG P/N
6505010519279
NSN
6505-01-051-9279
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
3-0758-53
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010519280
NSN
6505-01-051-9280
3-0758-53
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010519280
NSN
6505-01-051-9280
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
PRONESTYL
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010519280
NSN
6505-01-051-9280
PRONESTYL
PROCAINAMIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010519280
NSN
6505-01-051-9280
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
486-1111-51
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505010519281
NSN
6505-01-051-9281
486-1111-51
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505010519281
NSN
6505-01-051-9281
MFG
BEACH PRODUCTS INC DBA BEACH PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS POTASSIUM PHOSPHATE, MONOBASIC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
K PHOS
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505010519281
NSN
6505-01-051-9281
K PHOS
POTASSIUM PHOSPHATE,MONOBASIC,TABLETS
NSN, MFG P/N
6505010519281
NSN
6505-01-051-9281
MFG
BEACH PRODUCTS INC DBA BEACH PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS POTASSIUM PHOSPHATE, MONOBASIC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
46-0461-99
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010519282
NSN
6505-01-051-9282
46-0461-99
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010519282
NSN
6505-01-051-9282
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
INDERAL
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010519282
NSN
6505-01-051-9282
INDERAL
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010519282
NSN
6505-01-051-9282
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
32-4020-11
QUINIDINE SULFATE CAPSULES,USP
NSN, MFG P/N
6505010519283
NSN
6505-01-051-9283
32-4020-11
QUINIDINE SULFATE CAPSULES,USP
NSN, MFG P/N
6505010519283
NSN
6505-01-051-9283
MFG
SOLVAY PHARMACEUTICALS INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
CIN-QUIN
QUINIDINE SULFATE CAPSULES,USP
NSN, MFG P/N
6505010519283
NSN
6505-01-051-9283
CIN-QUIN
QUINIDINE SULFATE CAPSULES,USP
NSN, MFG P/N
6505010519283
NSN
6505-01-051-9283
MFG
SOLVAY PHARMACEUTICALS INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PHENERGAN EXPECTORANT PLAIN
PROMETHAZINE HYDROCHLORIDE,CHLOROFORM,IPECAC FLUIDEXTRACT,AND POTASSIUM GUAIACOLSULFONATE SYRUP
NSN, MFG P/N
6505010519284
NSN
6505-01-051-9284
PHENERGAN EXPECTORANT PLAIN
PROMETHAZINE HYDROCHLORIDE,CHLOROFORM,IPECAC FLUIDEXTRACT,AND POTASSIUM GUAIACOLSULFONATE SYRUP
NSN, MFG P/N
6505010519284
NSN
6505-01-051-9284
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.000 MILLIGRAMS CITRIC ACID PER MILLILITER AND 8.800 MILLIGRAMS POTASSIUM GUAIACOLSULFONATE PER MILLILITER AND 1.000 MILLIGRAMS PROMETHAZINE HYDROCHLORIDE PER MILLILITER AND 39.400 MILLIGRAMS SODIUM CITRATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
41-0782-10
PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010519285
NSN
6505-01-051-9285
41-0782-10
PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010519285
NSN
6505-01-051-9285
MFG
COOPER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V PILOCARPINE HYDROCHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PILOMIOTIN
PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010519285
NSN
6505-01-051-9285
PILOMIOTIN
PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010519285
NSN
6505-01-051-9285
MFG
COOPER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V PILOCARPINE HYDROCHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
7-0T01-15
TRIMEPRAZINE TARTRATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010520505
NSN
6505-01-052-0505
7-0T01-15
TRIMEPRAZINE TARTRATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010520505
NSN
6505-01-052-0505
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MG TRIMEPRAZINE TARTRATE ACTIVE INGREDIENT;LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
TEMARIL
TRIMEPRAZINE TARTRATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010520505
NSN
6505-01-052-0505
TEMARIL
TRIMEPRAZINE TARTRATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010520505
NSN
6505-01-052-0505
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MG TRIMEPRAZINE TARTRATE ACTIVE INGREDIENT;LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
484-0H07-21
TRIAMTERENE CAPSULES,USP
NSN, MFG P/N
6505010520506
NSN
6505-01-052-0506
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DYRENIUM
TRIAMTERENE CAPSULES,USP
NSN, MFG P/N
6505010520506
NSN
6505-01-052-0506
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
161-0429-27
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010520507
NSN
6505-01-052-0507
161-0429-27
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010520507
NSN
6505-01-052-0507
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
58-0786-10
SULFACETAMIDE SODIUM OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010520508
NSN
6505-01-052-0508
58-0786-10
SULFACETAMIDE SODIUM OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010520508
NSN
6505-01-052-0508
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
SILVER PROTEIN MILD
SILVER PROTEIN,MILD,SOLUTION
NSN, MFG P/N
6505010520509
NSN
6505-01-052-0509
SILVER PROTEIN MILD
SILVER PROTEIN,MILD,SOLUTION
NSN, MFG P/N
6505010520509
NSN
6505-01-052-0509
MFG
CITY CHEMICAL CORP
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
41-0768-10
SILVER PROTEIN,MILD,SOLUTION
NSN, MFG P/N
6505010520510
NSN
6505-01-052-0510
41-0768-10
SILVER PROTEIN,MILD,SOLUTION
NSN, MFG P/N
6505010520510
NSN
6505-01-052-0510
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V SILVER PROTEIN, MILD ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, DROPPER
TOTAL PRIMARY CONTAINER QUANTITY: 10
